Post job

Aviragen Therapeutics's revenue is $351.4 million.

What is Aviragen Therapeutics's revenue?

Aviragen Therapeutics's annual revenue is $351.4M. Zippia's data science team found the following key financial metrics about Aviragen Therapeutics after extensive research and analysis.
  • Aviragen Therapeutics's revenue growth from 2020 to 2021 is 622.49%.
  • Aviragen Therapeutics has 125 employees, and the revenue per employee ratio is $2,810,936.
  • Aviragen Therapeutics's peak quarterly revenue was $192.2M in 2021(q4).
  • Aviragen Therapeutics peak revenue was $351.4M in 2021.
  • Aviragen Therapeutics annual revenue for 2021 was 351.4M, 622.49% growth from 2020.

On this page

Most recent quarter revenue
$192.2M (Q4'2021)
Company most recent quarter revenue
Peak revenue
$351.4M (2021)
Company peak revenue
Revenue / employee
$2.8M
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$192.2M (Q4'2021)
Company most recent quarter revenue
Peak revenue
$351.4M (2021)
Company peak revenue
Revenue / employee
$2.8M
Company revenue / employee

Aviragen Therapeutics financial information

CEOMeir Haber
Company TypePublic
Employees Number125
Date Founded1984
HeadquartersAlpharetta, Georgia
Number of Locations1
Revenue$351.4M
Net Income-$115,909,000
Tax Rate-0.0%
Total Assets$666,708,000
TickerAVIR

Aviragen Therapeutics jobs you might like

Aviragen Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Aviragen Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aviragen Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Aviragen Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aviragen Therapeutics. The data presented on this page does not represent the view of Aviragen Therapeutics and its employees or that of Zippia.

Aviragen Therapeutics may also be known as or be related to Aviragen Therapeutics, Aviragen Therapeutics Inc and Biota.